<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0015">
 <label>Table 3</label>
 <caption>
  <p>Off-label drugs against SARS-CoV-2 and COVID-19 disease [
   <xref rid="bib0450" ref-type="bibr">92</xref>].
  </p>
 </caption>
 <alt-text id="at0060">Table 3</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Drug</th>
    <th align="left">Class</th>
    <th align="left">Target</th>
    <th align="left">Dosage</th>
    <th align="left">References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">Camostat mesilate</td>
    <td align="left">Serine protease inhibitor</td>
    <td align="left">TMPRSS2</td>
    <td align="left">200 mg three times daily, for 2 weeks, per oral</td>
    <td align="left">[
     <xref rid="bib0365" ref-type="bibr">73</xref>,
     <xref rid="bib0370" ref-type="bibr">74</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Nafamostat mesilate</td>
    <td align="left">Serine protease inhibitor</td>
    <td align="left">TMPRSS2</td>
    <td align="left">240 mg daily, for 5 days, per oral</td>
    <td align="left">[
     <xref rid="bib0375" ref-type="bibr">75</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Chloroquine phosphate</td>
    <td align="left">Antimalarial drug</td>
    <td align="left">ACE2</td>
    <td align="left">250 mg daily until clinical convalescence, per oral</td>
    <td align="left">[
     <xref rid="bib0380" ref-type="bibr">78</xref>,
     <xref rid="bib0385" ref-type="bibr">79</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Hydroxychloroquine</td>
    <td align="left">Antimalarial drug</td>
    <td align="left">Endosome, pH elevation</td>
    <td align="left">400 mg loading dose twice daily at day 1, 200 mg twice daily for 4 days, or 600 mg for 6 days, or 400 mg for 5 days, per oral</td>
    <td align="left">[
     <xref rid="bib0390" ref-type="bibr">[80]</xref>, 
     <xref rid="bib0395" ref-type="bibr">[81]</xref>, 
     <xref rid="bib0400" ref-type="bibr">[82]</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Remdesivir</td>
    <td align="left">Antiviral drug</td>
    <td align="left">RdRp</td>
    <td align="left">200 mg loading dose at day 1, 100 mg for 9–13 days, per oral or intravenous</td>
    <td align="left">[
     <xref rid="bib0405" ref-type="bibr">[83]</xref>, 
     <xref rid="bib0410" ref-type="bibr">[84]</xref>, 
     <xref rid="bib0415" ref-type="bibr">[85]</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Lopinavir/ritonavir</td>
    <td align="left">Antiviral drug</td>
    <td align="left">Viral proteases</td>
    <td align="left">400 mg lopinavir and 100 mg ritonavir twice daily, for 14 days, per oral</td>
    <td align="left">[
     <xref rid="bib0420" ref-type="bibr">[86]</xref>, 
     <xref rid="bib0425" ref-type="bibr">[87]</xref>, 
     <xref rid="bib0430" ref-type="bibr">[88]</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Umifenovir</td>
    <td align="left">Antiviral drug</td>
    <td align="left">Membrane fusion, clathrin-mediated endocytosis</td>
    <td align="left">400 mg three times daily, for 9 days, per oral</td>
    <td align="left">[
     <xref rid="bib0435" ref-type="bibr">89</xref>,
     <xref rid="bib0440" ref-type="bibr">90</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Favipiravir</td>
    <td align="left">Antiviral drug</td>
    <td align="left">RdRp</td>
    <td align="left">6000 mg loading dose at day 1, 2, 400 mg for days 2–10, per oral</td>
    <td align="left">[
     <xref rid="bib0445" ref-type="bibr">91</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
